Frequently Searched

Will Biden's FDA Chief Embrace Innovation or Hinder It?

December 16, 2021

December 16, 2021

By Naomi Lopez

In what may end up being the most colossal bureaucratic red tape blunder this year, President Biden’s nomination for the Food and Drug Administration commissioner is now delayed due to a reported missed paperwork deadline that occurred last month. Dr. Robert Califf’s confirmation hearing to lead the FDA, arguably the nation’s most-important health-related agency during this global pandemic, is now likely delayed until after the new year.

Having previously led the agency under President Obama, Dr. Califf’s track record is well-known. But we live in a world of rapid advances in personalized medicine, wearable technology and ground-breaking treatments — and in this era of growing medical innovation, it’s particularly important that Americans understand the commissioner’s vision for guiding the agency.

Read the rest in The Orange County Register.

Naomi Lopez is the Director of Healthcare Policy at the Goldwater Institute.



More on this issue

Donate Now

Help all Americans live freer, happier lives. Join the Goldwater Institute as we defend and strengthen freedom in all 50 states.

Donate Now

Since 1988, the Goldwater Institute has been in the liberty business — defending and promoting freedom, and achieving more than 400 victories in all 50 states. Donate today to help support our mission.

We Protect Your Rights

Our attorneys defend individual rights and protect those who cannot protect themselves.

Need Help? Submit a case.

Get Connected to Goldwater

Sign up for the latest news, event updates, and more.